# Evaluation of the AMICUS RBCx System in Sickle Cell Patients

> **NCT02372877** · NA · COMPLETED · sponsor: **Fenwal, Inc.** · enrollment: 83 (actual)

## Conditions studied

- Sickle Cell Anemia

## Interventions

- **DEVICE:** Amicus Red Cell Exchange in SCD patients

## Key facts

- **NCT ID:** NCT02372877
- **Lead sponsor:** Fenwal, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2017-12-07
- **Final completion:** 2018-01-19
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2022-07-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02372877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02372877, "Evaluation of the AMICUS RBCx System in Sickle Cell Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02372877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*